Buy or sell Miromatrix Medical stock pre IPO via an EquityZen fund
Miromatrix Medical Stock
Miromatrix Medical's technology aims to develop fully-biological replacement organs for the human body.
About Miromatrix Medical Stock
The Miromatrix Medical technology has the potential to enable the creation of fully biological replacement organs for the human body. In addition to the Company’s internal efforts focused on the development of its first product – a biomesh for hernia repair and breast reconstruction – scientists around the globe are working with the Company’s technology and are taking the first steps toward the creation of human organs including the liver, lung, kidney, pancreas and heart. It is our intent to retain laser focus on our Biomesh development program internally, while partnering with the best among those external groups already working with our technology in order to utilize this pre-existing expertise to develop individual products in the most efficacious, cost-effective and timely way possible.
President and CEO